Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36
Surveillance Infection Diseases by National Reference Centres Human Microbiology: Drug resistentie bij DNA virussen Last updated: 2022-04-08 16:04